Newman, L.S., Rose, C.S., Bresnitz, E.A., Rossman, M.D., Barnard, J., Frederick, M., Terrin, M.L., Weinberger, S.E., Moller, D.R., McLennan, G., Hunninghake, G., DePalo, L., Baughman, R.P., Iannuzzi, M.C., Judson, M.A., Knatterud, G.L., Thompson, B.W., Teirstein, A.S., Yeager, H., Jr Johns, C.J., Rabin, D.L., Rybicki, B.A. and Cherniack, R. (2004) ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis: Environmental and Occupational Risk Factors. American Journal of Respiratory and Critical Care Medicine, 170, 1324-1330.

has been cited by the following article:

• TITLE: Musculcutanous Sarcoidosis Following Intramuscular Injection of Synthol; Case Study

  AUTHORS: Medhat Ahmed Fouad Shalaby, Mamdooh Ahmed Khairy, Sameh Hassan al Zayat, Samy Abd Alhakim

  KEYWORDS: Sarcoidosis, Synthol

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.10 No.2, February 11, 2022

  ABSTRACT: Sarcoidosis is a non caseating granulomatous disease of unknown etiology. Many factors may be attributed to the occurrence of that granuloma including the chemical factors. We present this case aiming to highlight Synthol injection which is chemical substance frequently used by athletics to increase their muscle size as it can trigger the occurrence of musculocutanous sarcoidosis. In conclusion Synthol should be added to the chemical list which can induce musculocutanous sarcoidosis.